Related references
Note: Only part of the references are listed.Non-interventional surveillance study of adverse events in patients with epilepsy
J. A. Cramer et al.
ACTA NEUROLOGICA SCANDINAVICA (2011)
Efficacy of New Antiepileptic Drugs
Dieter Schmidt
EPILEPSY CURRENTS (2011)
Developmental and epilepsy outcomes at age 4 years in the UKISS trial comparing hormonal treatments to vigabatrin for infantile spasms: a multi-centre randomised trial
Katrina Darke et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2010)
A Pooled Analysis of Lacosamide Clinical Trial Data Grouped by Mechanism of Action of Concomitant Antiepileptic Drugs
John-Kenneth Sake et al.
CNS DRUGS (2010)
Posttraumatic epilepsy
Irina Kharatishvili et al.
CURRENT OPINION IN NEUROLOGY (2010)
Efficacy, tolerability, and safety of rapid initiation of topiramate versus phenytoin in patients with new-onset epilepsy: A randomized double-blind clinical trial
Eugene Ramsay et al.
EPILEPSIA (2010)
Lacosamide as adjunctive therapy for partial-onset seizures: A randomized controlled trial
Steve Chung et al.
EPILEPSIA (2010)
When clinical trials make history: Demonstrating efficacy of new antiepileptic drugs as monotherapy
Emilio Perucca
EPILEPSIA (2010)
Placebo-corrected efficacy of modern antiepileptic drugs for refractory epilepsy: Systematic review and meta-analysis
Stefan Beyenburg et al.
EPILEPSIA (2010)
Therapeutic approaches to epileptogenesis-Hope on the horizon
Asla Pitkanen
EPILEPSIA (2010)
Historical control monotherapy design in the treatment of epilepsy
Jacqueline A. French et al.
EPILEPSIA (2010)
Functional, metabolic, and synaptic changes after seizures as potential targets for antiepileptic therapy
Wolfgang Loescher et al.
EPILEPSY & BEHAVIOR (2010)
A comparison of pregabalin, lamotrigine, and placebo as adjunctive therapy in patients with refractory partial-onset seizures
Michel Baulac et al.
EPILEPSY RESEARCH (2010)
Key factors in the discovery and development of new antiepileptic drugs
Meir Bialer et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Invited Article: Comparative effectiveness research, evidence-based medicine, and the AAN
Jacqueline A. French et al.
NEUROLOGY (2010)
Use of antiepileptic drugs in epilepsy and the risk of self-harm or suicidal behavior
Frank Andersohn et al.
NEUROLOGY (2010)
Suicide-Related Events in Patients Treated with Antiepileptic Drugs
Alejandro Arana et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Ethosuximide, Valproic Acid, and Lamotrigine in Childhood Absence Epilepsy.
Tracy A. Glauser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Prevention or Modification of Epileptogenesis after Brain Insults: Experimental Approaches and Translational Research
Wolfgang Loescher et al.
PHARMACOLOGICAL REVIEWS (2010)
WHAT IS AN EPILEPTIC SEIZURE? UNIFYING DEFINITIONS IN CLINICAL PRACTICE AND ANIMAL RESEARCH TO DEVELOP NOVEL TREATMENTS
Raimondo D'Ambrosio et al.
EPILEPSY CURRENTS (2010)
Levetiracetam for managing neurologic and psychiatric disorders
Muhammad U. Farooq et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2009)
Early seizure frequency and aetiology predict long-term medical outcome in childhood-onset epilepsy
Matti Sillanp et al.
BRAIN (2009)
Refractory Gastro-Oesophageal Reflux Disease Diagnosis and Management
Julia J. Liu et al.
DRUGS (2009)
Drug treatment of epilepsy in the century of the ILAE: The first 50 years, 1909-1958
Simon D. Shorvon
EPILEPSIA (2009)
Posttraumatic epilepsy: The challenge of translating discoveries in the laboratory to pathways to a cure
Marc A. Dichter
EPILEPSIA (2009)
Preventing and treating posttraumatic seizures: The human experience
Nancy R. Temkin
EPILEPSIA (2009)
Drug treatment of epilepsy in the century of the ILAE: The second 50 years, 1959-2009
Simon D. Shorvon
EPILEPSIA (2009)
Drug treatment of epilepsy: Options and limitations
Dieter Schmidt
EPILEPSY & BEHAVIOR (2009)
Progress report on new antiepileptic drugs: A summary of the Ninth Eilat Conference (EILAT IX)
Meir Bialer et al.
EPILEPSY RESEARCH (2009)
Preclinical assessment of proconvulsant drug activity and its relevance for predicting adverse events in humans
Wolfgang Loescher
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Pharmacodynamic interactions between antiepileptic drugs: preclinical data based on isobolography
Stanislaw J. Czuczwar et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2009)
THE LITTLE COMPOUND THAT COULD How Phenytoin Changed Drug Discovery and Development
Rebecca J. Anderson
MOLECULAR INTERVENTIONS (2009)
Epileptogenesis in the immature brain: emerging mechanisms
Sanjay N. Rakhade et al.
NATURE REVIEWS NEUROLOGY (2009)
Teratogenic Effects of Antiepileptic Medications
Torbjorn Tomson et al.
NEUROLOGIC CLINICS (2009)
Levetiracetam in spinal cord injury pain: a randomized controlled trial
N. B. Finnerup et al.
SPINAL CORD (2009)
NEW DEVELOPMENTS IN ANTIEPILEPTIC DRUG RESISTANCE: AN INTEGRATIVE VIEW
Dieter Schmidt et al.
EPILEPSY CURRENTS (2009)
Designing Clinical Trials to Assess Antiepileptic Drugs as Monotherapy Difficulties and Solutions
Emilio Perucca
CNS DRUGS (2008)
New molecular targets for Antiepileptic drugs:: α2δ, SV2A, and Kv7/KCNQ/M potassium channels
Michael A. Rogawski et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2008)
Modern management of epilepsy: A practical approach
Christian E. Elger et al.
EPILEPSY & BEHAVIOR (2008)
Rufinamide for generalized seizures associated with Lennox-Gastaut syndrome
T. Glauser et al.
NEUROLOGY (2008)
Intrinsic Severity as a Determinant of Antiepileptic Drug Refractoriness
Michael A. Rogawski et al.
Epilepsy Currents (2008)
Quantifying the response to antiepileptic drugs
Yitzhak Schiller et al.
NEUROLOGY (2008)
Non-inferiority trials are unethical because they disregard patients' interests
Silvio Garattini et al.
LANCET (2007)
Results of treatment changes in patients with apparently drug-resistant chronic epilepsy
Anna L. Luciano et al.
ANNALS OF NEUROLOGY (2007)
Likelihood of seizure remission in an adult population with refractory epilepsy
Brian C. Callaghan et al.
ANNALS OF NEUROLOGY (2007)
An international multicenter randomized double-blind controlled trial of lamotrigine and sustained-release carbamazepine in the treatment of newly diagnosed epilepsy in the elderly
Erik Saetre et al.
EPILEPSIA (2007)
Outcomes of newly diagnosed idiopathic generalized epilepsy syndromes in a non-pediatric setting
R. Mohanraj et al.
ACTA NEUROLOGICA SCANDINAVICA (2007)
Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy
M. J. Brodie et al.
NEUROLOGY (2007)
Negative effects of Antiepileptic drugs on mood in patients with epilepsy
Marco Mula et al.
DRUG SAFETY (2007)
Discovery of Antiepileptic drugs
Misty Smith et al.
NEUROTHERAPEUTICS (2007)
Development of new antiepileptic drugs: challenges, incentives, and recent advances
Emilio Perucca et al.
LANCET NEUROLOGY (2007)
The multidrug transporter hypothesis of drug resistance in epilepsy:: Proof-of-principle in a rat model of temporal lobe epilepsy
Claudia Brandt et al.
NEUROBIOLOGY OF DISEASE (2006)
Experimental and clinical evidence for loss of effect (tolerance) during prolonged treatment with antiepileptic drugs
Wolfgang Loescher et al.
EPILEPSIA (2006)
ILAE treatment guidelines: Evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes
Tracy Glauser et al.
EPILEPSIA (2006)
Molecular and cellular mechanisms of pharmacoresistance in epilepsy
S Remy et al.
BRAIN (2006)
Drug resistance in brain diseases and the role of drug efflux transporters
W Löscher et al.
NATURE REVIEWS NEUROSCIENCE (2005)
Outcomes in newly diagnosed localization-related epilepsies
R Mohanraj et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2005)
Drug resistance in epilepsy:: Putative neurobiologic and clinical mechanisms
D Schmidt et al.
EPILEPSIA (2005)
The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions
MA Rogawski et al.
NATURE MEDICINE (2004)
The neurobiology of antiepileptic drugs
MA Rogawski et al.
NATURE REVIEWS NEUROSCIENCE (2004)
Conversion to monotherapy - Clinical trials in patients with refractory partial seizures
A Beydoun et al.
NEUROLOGY (2003)
Mechanisms of antiepileptic drug resistance
SM Sisodiya
CURRENT OPINION IN NEUROLOGY (2003)
Preclinical development of antiepileptic drugs: Past, present, and future directions
HS White
EPILEPSIA (2003)
Do preclinical seizure models preselect certain adverse effects of antiepileptic drugs
B Meldrum
EPILEPSY RESEARCH (2002)
New horizons in the development of antiepileptic drugs
W Löscher et al.
EPILEPSY RESEARCH (2002)
Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs.: A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy
W Löscher
EPILEPSY RESEARCH (2002)
Use of epileptic animals for adverse effect testing
H Klitgaard et al.
EPILEPSY RESEARCH (2002)
Seizure reduction and quality of life improvements in people with epilepsy
GL Birbeck et al.
EPILEPSIA (2002)
Pharmacological characterization of the 6 Hz psychomotor seizure model of partial epilepsy
ME Barton et al.
EPILEPSY RESEARCH (2001)
Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial
C Chiron et al.
LANCET (2000)
Gabapentin versus vigabatrin as first add-on for patients with partial seizures that failed to respond to monotherapy:: A randomized, double-blind, dose titration study
M Lindberger et al.
EPILEPSIA (2000)
Early identification of refractory epilepsy.
P Kwan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
The anticonvulsant SGB-017 (ADCI) blocks voltage-gated sodium channels in rat and human neurons: Comparison with carbamazepine
L Sun et al.
EPILEPSIA (2000)
Share Paper
